[1]Maomao C, He L, Dianqin S, et al. Current cancer burden in China: epidemiology, etiology, and prevention[J]. Cancer Biol Med, 2022, 19(8): 1121-1138.
[2]Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590.
[3]Yates AG, Pink RC, Erdbrügger U, et al. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo: Part Ⅱ: Pathology: Part Ⅱ: Pathology[J]. J Extracell Vesicles, 2022, 11(1): e12190.
[4]Cappello F, Fais S. Extracellular vesicles in cancer pros and cons: the importance of the evidencebased medicine[J]. Semin Cancer Biol, 2022, 86(Pt 1): 4-12.
[5]AraujoAbad S, Saceda M, de Juan Romero C. Biomedical application of small extracellular vesicles in cancer treatment[J]. Adv Drug Deliv Rev, 2022, 182: 114117.
[6]倪修凡, 张尤历, 徐岷. 外泌体源性长链非编码RNA在消化系统肿瘤中的研究进展[J]. 江苏大学学报(医学版), 2020, 30(4): 293-297, 301.
[7]Wang S, Xu M, Li X, et al. Exosomes released by hepatocarcinoma cells endow adipocytes with tumorpromoting properties[J]. J Hematol Oncol, 2018, 11(1): 82.
[8]Fang JH, Zhang ZJ, Shang LR, et al. Hepatoma cellsecreted exosomal microRNA103 increases vascular permeability and promotes metastasis by targeting junction proteins[J]. Hepatology, 2018, 68(4): 1459-1475.
[9]Fang T, Lv H, Lv G, et al. Tumorderived exosomal miR12473p induces cancerassociated fibroblast activation to foster lung metastasis of liver cancer[J]. Nat Commun, 2018, 9(1): 191.
[10]Hu Y, Qi C, Liu X, et al. Malignant ascitesderived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer[J]. Cancer Lett, 2019, 457: 142-150.
[11]Zhang H, Zhu L, Bai M, et al. Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR133/PRDM16 pathway[J]. Int J Cancer, 2019, 144(10): 2501-2515.
[12]Li W, Zhang L, Guo B, et al. Exosomal FMR1AS1 facilitates maintaining cancer stemlike cell dynamic equilibrium via TLR7/NFκB/cMyc signaling in female esophageal carcinoma[J]. Mol Cancer, 2019, 18(1): 22.
[13]Zhang H, Deng T, Liu R, et al. CAF secreted miR522 suppresses ferroptosis and promotes acquired chemoresistance in gastric cancer[J]. Mol Cancer, 2020, 19(1): 43.
[14]Kang M, Ren M, Li Y, et al. Exosomemediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA[J]. J Exp Clin Cancer Res, 2018, 37(1): 171.
[15]Gwak HK, Lee JH, Park SG. Preliminary evaluation of clinical utility of CYFRA 211, CA 724, NSE, CA199 and CEA in stomach cancer[J]. Asian Pac J Cancer Prev, 2014, 15(12): 4933-4938.
[16]Hoshino A, Kim HS, Bojmar L, et al. Extracellular vesicle and particle biomarkers define multiple human cancers[J]. Cell, 2020, 182(4): 1044-1061.
[17]Jia Y, Yu L, Ma T, et al. Small extracellular vesicles isolation and separation: current techniques, pending questions and clinical applications[J]. Theranostics, 2022, 12(15): 6548-6575.
[18]Tanaka Y, Kamohara H, Kinoshita K, et al. Clinical impact of serum exosomal microRNA21 as a clinical biomarker in human esophageal squamous cell carcinoma[J]. Cancer, 2013, 119(6): 1159-1167.
[19]Luo A, Zhou X, Shi X, et al. Exosomederived miR3395p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma[J]. Oncogene, 2019, 38(25): 4990-5006.
[20]Fan L, Cao Q, Liu J, et al. Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis[J]. Mol Cancer, 2019, 18(1): 16.
[21]Li K, Lin Y, Luo Y, et al. A signature of salivaderived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study[J]. Mol Cancer, 2022, 21(1): 21.
[22]Li B, Xia Y, Lv J, et al. miR151a3prich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemnessenhancing niche[J]. Oncogene, 2021, 40(43): 6180-6194.
[23]Xin L, Zhou LQ, Liu C, et al. Transfer of LncRNA CRNDE in TAMderived exosomes is linked with cisplatin resistance in gastric cancer[J]. EMBO Rep, 2021, 22(12): e52124.
[24]Xie M, Yu T, Jing X, et al. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR5823p/HUR/VEGF axis and suppressing HSP90 degradation[J]. Mol Cancer, 2020, 19(1): 112.
[25]Matsumura T, Sugimachi K, Iinuma H, et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer[J]. Br J Cancer, 2015, 113(2): 275-281.
[26]Teng Y, Ren Y, Hu X, et al. MVPmediated exosomal sorting of miR193a promotes colon cancer progression[J]. Nat Commun, 2017, 8: 14448.
[27]Zheng R, Zhang K, Tan S, et al. Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3eIF3h interaction[J]. Mol Cancer, 2022, 21(1): 49.
[28]Sun B, Li Y, Zhou Y, et al. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer[J]. J Cell Physiol, 2019, 234(2): 1416-1425.
[29]Soldevilla B, Rodríguez M, San Milln C, et al. Tumorderived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival[J]. Hum Mol Genet, 2014, 23(2): 467-478.
[30]Lu JC, Zhang PF, Huang XY, et al. Amplification of spatially isolated adenosine pathway by tumormacrophage interaction induces antiPD1 resistance in hepatocellular carcinoma[J]. J Hematol Oncol, 2021, 14(1): 200.
[31]Nakamura K, Zhu Z, Roy S, et al. An exosomebased transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter cohort study[J]. Gastroenterology, 2022, 163(5): 1252-1266.
[32]Xie Z, Gao Y, Ho C, et al. Exosomedelivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment[J]. Gut, 2022, 71(3): 568-579.
[33]Melo SA, Luecke LB, Kahlert C, et al. Glypican1 identifies cancer exosomes and detects early pancreatic cancer[J]. Nature, 2015, 523(7559): 177-182.
[34]Sun H, Wang C, Hu B, et al. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3[J]. Signal Transduct Target Ther, 2021, 6(1): 187.
[35]Wang Z, Li Y, Mao R, et al. DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer[J]. Cell Death Dis, 2022, 13(2): 151.
[36]Li J, Li Y, Chen S, et al. Highly sensitive exosome detection for early diagnosis of pancreatic cancer using immunoassay based on hierarchical surfaceenhanced Raman scattering substrate[J]. Small Methods, 2022, 6(6): e2200154.
[37]Guo X, Lv X, Ru Y, et al. Circulating exosomal gastric cancerassociated long noncoding RNA1 as a biomarker for early detection and monitoring progression of gastric cancer: a multiphase study[J]. JAMA Surg, 2020, 155(7): 572-579.
[38]Roy S, Kanda M, Nomura S, et al. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer[J]. Mol Cancer, 2022, 21(1): 42.
[39]Wang Y, Weng Q, Ge J, et al. tRNAderived small RNAs: mechanisms and potential roles in cancers[J]. Genes Dis, 2022, 9(6): 1431-1442.
[40]江佳佳, 吴佩佩, 许文荣. 肿瘤外泌体标志物应用及靶向治疗进展[J]. 江苏大学学报(医学版), 2021, 31(1): 11-16.
[41]Xu J, Ji L, Liang Y, et al. CircRNASORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1[J]. Signal Transduct Target Ther, 2020, 5(1): 298.
[42]Zhou W, Zhou Y, Chen X, et al. Pancreatic cancertargeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment[J]. Biomaterials, 2021, 268: 120546.
[43]Xu L, Faruqu FN, LiamOr R, et al. Design of experiment (DoE)driven in vitro and in vivo uptake studies of exosomes for pancreatic cancer delivery enabled by copperfree click chemistrybased labelling[J]. J Extracell Vesicles, 2020, 9(1): 1779458.
[44]Gong C, Zhang X, Shi M, et al. Tumor exosomes reprogrammed by low pH are efficient targeting vehicles for smart drug delivery and personalized therapy against their homologous tumor[J]. Adv Sci (Weinh), 2021, 8(10): 2002787.
[45]Lu Z, Zuo B, Jing R, et al. Dendritic cellderived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models[J]. J Hepatol, 2017, 67(4): 739-748.
[46]Yu Z, Lin S, Xia F, et al. ExoSD chips for highpurity immunomagnetic separation and highsensitivity detection of gastric cancer cellderived exosomes[J]. Biosens Bioelectron, 2021, 194: 113594.
|